Cargando…

1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?

BACKGROUND: Cryptococcus sp. is a major cause of opportunistic infections in immunocompromised patients, with nearly all cases due to C. neoformans or C. gattii. There are occasional reports of other Cryptococcus species causing invasive human disease. However, their epidemiology and clinical signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Cano Cevallos, Edison J, Yetmar, Zachary A, Razonable, Raymund R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809642/
http://dx.doi.org/10.1093/ofid/ofz360.1555
_version_ 1783462040901255168
author Cano Cevallos, Edison J
Yetmar, Zachary A
Razonable, Raymund R
author_facet Cano Cevallos, Edison J
Yetmar, Zachary A
Razonable, Raymund R
author_sort Cano Cevallos, Edison J
collection PubMed
description BACKGROUND: Cryptococcus sp. is a major cause of opportunistic infections in immunocompromised patients, with nearly all cases due to C. neoformans or C. gattii. There are occasional reports of other Cryptococcus species causing invasive human disease. However, their epidemiology and clinical significance are not fully defined. We sought to describe the patients with cultures positive for Cryptococcus species other than neoformans and gattii. METHODS: A retrospective descriptive review of patients with cultures growing Cryptococcus species other than neoformans and gattii from November 2011 to February 2019. Clinical and laboratory data were analyzed. RESULTS: Out of 177 cases with a culture positive for Cryptococcus sp., 54 patients (mean age, 53.3 years; 61% men) had a culture for Cryptococcus other than neoformans and gattii. The most common species were unspecified non-neoformans/gattii (10), magnus (9), laurentii (8), and ater (7). Three patients had active malignancies and 15 were on immunosuppressive drugs, 6 due to transplant. The most common sites or specimens were skin (16), respiratory (16), urine (7), joint (3), intravascular catheter (2), cerebrospinal fluid (2), oral (2), peritoneal fluid, donor liver transplant, bone marrow, sinus, nail, and cornea. Whereas 21 (38.9%) cultures were obtained due to local symptoms, there was only one case of invasive disease, affecting the peritoneum, while the majority was either unaddressed (25) or considered contaminants (17). Only 12 patients received antifungal treatment, where sources were skin (4), oral (2), peritoneum, donor liver, respiratory, vascular catheter, urine, and nail. Antifungal drugs were fluconazole, itraconazole, clotrimazole, caspofungin, and griseofulvin, for a mean duration of 37.6 days. Among patients who were not treated, four died within 6 months but mostly of unrelated causes (3) or not known (1). CONCLUSION: This large series of patients with Cryptococcus sp. other than neoformans and gattii suggests that these species rarely cause clinically significant infection in humans. Only one case of invasive disease was found. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809642
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68096422019-10-28 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant? Cano Cevallos, Edison J Yetmar, Zachary A Razonable, Raymund R Open Forum Infect Dis Abstracts BACKGROUND: Cryptococcus sp. is a major cause of opportunistic infections in immunocompromised patients, with nearly all cases due to C. neoformans or C. gattii. There are occasional reports of other Cryptococcus species causing invasive human disease. However, their epidemiology and clinical significance are not fully defined. We sought to describe the patients with cultures positive for Cryptococcus species other than neoformans and gattii. METHODS: A retrospective descriptive review of patients with cultures growing Cryptococcus species other than neoformans and gattii from November 2011 to February 2019. Clinical and laboratory data were analyzed. RESULTS: Out of 177 cases with a culture positive for Cryptococcus sp., 54 patients (mean age, 53.3 years; 61% men) had a culture for Cryptococcus other than neoformans and gattii. The most common species were unspecified non-neoformans/gattii (10), magnus (9), laurentii (8), and ater (7). Three patients had active malignancies and 15 were on immunosuppressive drugs, 6 due to transplant. The most common sites or specimens were skin (16), respiratory (16), urine (7), joint (3), intravascular catheter (2), cerebrospinal fluid (2), oral (2), peritoneal fluid, donor liver transplant, bone marrow, sinus, nail, and cornea. Whereas 21 (38.9%) cultures were obtained due to local symptoms, there was only one case of invasive disease, affecting the peritoneum, while the majority was either unaddressed (25) or considered contaminants (17). Only 12 patients received antifungal treatment, where sources were skin (4), oral (2), peritoneum, donor liver, respiratory, vascular catheter, urine, and nail. Antifungal drugs were fluconazole, itraconazole, clotrimazole, caspofungin, and griseofulvin, for a mean duration of 37.6 days. Among patients who were not treated, four died within 6 months but mostly of unrelated causes (3) or not known (1). CONCLUSION: This large series of patients with Cryptococcus sp. other than neoformans and gattii suggests that these species rarely cause clinically significant infection in humans. Only one case of invasive disease was found. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809642/ http://dx.doi.org/10.1093/ofid/ofz360.1555 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Cano Cevallos, Edison J
Yetmar, Zachary A
Razonable, Raymund R
1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title_full 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title_fullStr 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title_full_unstemmed 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title_short 1691. Cryptococcus Species Other than C. neoformans and C. gattii: Are They Clinically Significant?
title_sort 1691. cryptococcus species other than c. neoformans and c. gattii: are they clinically significant?
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809642/
http://dx.doi.org/10.1093/ofid/ofz360.1555
work_keys_str_mv AT canocevallosedisonj 1691cryptococcusspeciesotherthancneoformansandcgattiiaretheyclinicallysignificant
AT yetmarzacharya 1691cryptococcusspeciesotherthancneoformansandcgattiiaretheyclinicallysignificant
AT razonableraymundr 1691cryptococcusspeciesotherthancneoformansandcgattiiaretheyclinicallysignificant